Imported-post

Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19. Read More

Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments. Read More

Vanderbilt researchers suggest that to reduce treatment-related regret for men with localized prostate cancer, treatment preparation should focus on shared decision-making and aligning patient expectations with treatment toxicity. Read More

In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients. Read More

New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter. Read More

Researchers in the Endocrine Neoplasia Research Laboratory at Vanderbilt University Medical Center have received national recognition for their work to discover better treatments for thyroid cancer. A paper describing their lab work was awarded first place in the Basic Science category at the 2021 Cancer Research Competition. Read More

Researchers across four health care systems, including Vanderbilt University Medical Center, have found that increased depression polygenic scores are associated with increased white blood cell count, highlighting the importance of the immune system in the etiology of depression. Read More

Kolouri wins $1M DARPA grant to investigate AI cooperative lifelong learning A Vanderbilt engineering professor is leading part of an international initiative to create advanced artificial intelligence programs that will enable machines to learn progressively over a lifetime and share those experiences with each other. Researchers hope the technology will allow machines to reuse information,... Read More

A study by Vanderbilt researchers sheds light on how current antidepressant drugs work and suggests a new drug target in depression. Read More

A paper by Vanderbilt engineers that explores the scope to scale up the sizes of atomically thin membranes and their potential use in applications relating to energy, microscopy, and electronics is published in the journal Science. Authors Piran R. Kidambi, assistant professor of chemical and biomolecular engineering, Pavan Chaturvedi, postdoctoral scholar in the Department of... Read More

A study led by researchers from Vanderbilt University’s Center for Rehabilitation Engineering and Assistive Technology reveals a breakthrough tool to assess the effect of exoskeletons on injury risk. The tool, called Exo-LiFFT, is an interactive calculator that will help companies looking for ways to overcome workforces struggling with musculoskeletal injuries, missed work, and accelerated retirement... Read More

  by Bill Snyder In a multidisciplinary collaboration, researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer (TNBC) that appears to be able to escape detection by the immune system and evade immunotherapy. Their report, published Nov. 1 in the journal... Read More

Vanderbilt biomedical engineering professor has developed a prototype headband to measure brain activity that could have widespread application in studying and ultimately treating ADHD and other neurological disorders. The device is lightweight, portable, and inexpensive to construct. Prototype components cost less than $250, compared to costs exceeding $10,000 for commercial systems. Audrey Bowden, associate professor... Read More

Vanderbilt biomedical engineering professor has developed a prototype headband to measure brain activity that could have widespread application in studying and ultimately treating ADHD and other neurological disorders. The device is lightweight, portable, and inexpensive to construct. Prototype components cost less than $250, compared to costs exceeding $10,000 for commercial systems. Audrey Bowden, associate professor... Read More

Vanderbilt researchers used a machine learning algorithm and data from more than 26,000 hospital stays to predict who would and would not be discharged over the next 24 hours. Read More

Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered. Read More

Minimizing variation in how rejection is diagnosed and creating standardized surveillance protocols may help inform best practices in pediatric heart transplants. Read More

A combination of two broadly acting monoclonal antibodies isolated by researchers at Vanderbilt University Medical Center protected non-human primates from ebolavirus disease, which causes severe and often-fatal hemorrhagic fever in humans. Read More

“High contrast cleavage detection for enhancing porous silicon sensor sensitivity” published in Optics Express has been selected as a VINSE spotlight publication. Read More

Center aims to advance the understanding of physical mechanisms responsible for radiation-induced effects on emerging technologies The Institute for Space and Defense Electronics at Vanderbilt University has been selected as the Center of Excellence in Radiation Effects by the U.S. Air Force Office of Scientific Research and the Air Force Research Lab. The $5 million, five-year program will be... Read More